Thyroid Ablation Devices Market to Gain $1,294.43 Million by 2030, At 10.6% CAGR

Growth of the global thyroid ablation devices market is majorly driven by increase in prevalence of thyroid cancer and thyroid nodules; increase in demand of minimally invasive surgeries; and increase in availability of new technologically advanced products for the thyroid ablation. Therefore, these aforementioned factors increase the use of thyroid ablation, which drives the growth of the thyroid ablation devices market. According to the American Cancer Society’s (ACS) publications, Cancer Facts & Figures 2021 and Cancer Facts & Figures 2020, an estimated 44,280 adults (12,150 men and 32,130 women) in the U.S. were diagnosed with thyroid cancer.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐑𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 – 𝐂𝐎𝐕𝐈𝐃-19 𝐈𝐦𝐩𝐚𝐜𝐭 𝐚𝐧𝐝 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐰𝐢𝐭𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐭:https://www.alliedmarketresearch.com/request-sample/13940

The key players operating in the global thyroid ablation devices market include Boston Scientific Corporation, BVM Medical System, Integra LifeSciences, Johnson & Johnson, Medtronic Plc, Medwaves Inc., Olympus Corporation, STARmed Co., Ltd., Terumo Corporation and Theraclion.

Thyroid cancer is the seventh most common cancer in women. Due to the increasing burden of thyroid cancer, the number of ablation surgeries is increasing. In addition, thyroid nodules are also on the rise as they are one of the most common diseases of the endocrine system. These aforementioned factors have led to an increase in the use of thyroid ablation in the treatment of thyroid cancer and nodules and are expected to drive the growth of the thyroid ablation devices market in the near future. Moreover, advanced ablation technology is expected to drive thegrowth of thyroid ablation devices market over the forecast period

Thyroid ablation devices are majorly used for the treatment of thyroid cancer, and thyroid nodules. A thyroid nodule is an unusual growth (lump) of thyroid cells in the thyroid gland. Thyroid cancer is a solid tumor cancer that usually shows up as a nodule, or mass, in the thyroid gland, which is located at the front base of your throat. It occurs when rogue cells reproduce too rapidly for the immune system to control. There are several types of thyroid cancer, but two types — papillary thyroid cancer and follicular thyroid cancer — are by far the most common, accounting for some 95 percent of cases.

The ablation technique is used to treat the tumors and nodules minimally invasively to reduce the size of thyroid nodules and restore thyroid function. Radiofrequency Ablation (RFA) is a minimally-invasive technique performed by an endocrine surgeon guided by ultrasound imaging. The physician delivers targeted radio waves that disrupts the nodule’s cells, causing them to shrink as the body absorbs the ablated tissue. RFA also enables patients to resume normal daily activity with minimal recovery time. While surgery may involve removing part of the thyroid, RFA maintains thyroid integrity, which supports improved thyroid function.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭:https://www.alliedmarketresearch.com/connect-to-analyst/13940